(Q40142266)

17 September 2017

1 reference

title

Small cell lung cancer 1973-1983: early progress and recent obstacles (English)

1 reference

17 September 2017

Small cell lung cancer 1973–1983: Early progress and recent obstacles (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

29 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

29 September 2023

author name string

G. Morstyn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

D. C. Ihde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

A. S. Lichter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

P. A. Bunn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

D. N. Carney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

E. Glatstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

J. D. Minna

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6327578

29 September 2023

language of work or name

English

0 references

publication date

1 April 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0360301684900324?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

https://api.elsevier.com/content/article/PII:0360301684900324?httpAccept=text/plain

29 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

International Journal of Radiation Oncology Biology Physics

29 September 2023

published in

1 reference

17 September 2017

volume

10

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

515-539

1 reference

Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung

29 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Doxorubicin, cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer

29 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations

29 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung

29 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung

29 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse

29 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer

29 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications

29 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid

29 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide

29 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

High-dose cisplatin for lung cancer

29 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Role of radiation therapy in small cell anaplastic carcinoma of the lung

29 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Endocrine function in small cell undifferentiated carcinoma of the lung

29 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer

29 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Mixed Anaplastic Small-Cell and Squamous-Cell Carcinoma of the Lung

29 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Growth rates of small cell bronchogenic carcinomas

29 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Treatment of bronchogenic carcinoma. II. Small cell

29 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy

29 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Advances in small cell bronchogenic carcinoma

29 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Streptozotocin in advanced small cell bronchogenic carcinoma: an ineffective nonmyelosuppressive agent

29 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Brain Metastases in Small Cell Carcinoma of the Lung

29 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung

29 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung

29 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Experimental studies of the biology of human small cell lung cancer

29 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung

29 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants

29 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.

29 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Small cell lung cancer: Analysis of treatment factors contributing to prolonged survival

29 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy

29 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Treatment of small cell lung cancer: Progress, potential and problems

29 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma

29 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Intensive chemotherapy of small cell bronchogenic carcinoma

29 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma

29 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Small cell carcinoma of the lung

29 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Results of whole-brain irradiation for metastases from small cell carcinoma of the lung

29 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578)

29 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes

29 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Monoclonal antibodies that demonstrate specificity for several types of human lung cancer

29 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A phase II clinical study of mAMSA in small cell carcinoma of the lung

29 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Results of a pilot study of wide field radiotherapy in the treatment of oat cell carcinoma of the bronchus

29 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Failure of low-dose, total-body irradiation to augment combination chemotherapy in extensive-stage small cell carcinoma of the lung

29 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer

29 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival

29 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Long-term results in combined-modality treatment of small cell carcinoma of the lung

29 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Complications in the treatment of small cell carcinoma of the lung

29 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

29 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A randomized study: Small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy

29 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung

29 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung

29 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lung

29 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Alkylating agents in bronchogenic carcinoma

29 September 2023

80

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer

29 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy

29 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung

29 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)

29 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy

29 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy

29 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma

29 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Bone marrow involvement in small cell anaplastic carcinoma of the lung: prognostic and therapeutic aspects

29 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Histopathologic classification of small cell carcinoma of the lung. Comments based on an interobserver examination

29 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Intracranial metastases in small cell carcinoma of the lung. Correlation of clinical and autopsy findings

29 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Integration of chemotherapy and radiation therapy for small cell carcinoma of the lung

29 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse

29 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung

29 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology Association

29 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure

29 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

“Total” Therapy for Small Cell Carcinoma of the Lung

29 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Human lymphoblastoid interferon in the treatment of small cell lung cancer

29 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma

29 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation

29 September 2023

110

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II trial of cisplatin in small cell carcinoma of the lung

29 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: A Southwest Oncology group study

29 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A southwest oncology group study

29 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Acute leukemia following intensive therapy for small-cell carcinoma of the lung

29 September 2023

119

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Streptozotocin: an inactive agent in small cell carcinoma

29 September 2023

123

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study

29 September 2023

124

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

29 September 2023

125

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma

29 September 2023

130

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A phase II trial of m-AMSA in patients with small-cell lung cancer

29 September 2023

132

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II trial of vindesine in patients with small cell lung carcinoma

29 September 2023

133

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Combination cis-platinum and etoposide in small-cell lung cancer

29 September 2023

134

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B

29 September 2023

135

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

29 September 2023

136

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II study of procarbazine in small cell carcinoma of the lung

29 September 2023

139

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Long term survivors with small cell carcinoma of the lung

29 September 2023

141

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Clinical research on the treatment of locally advanced lung cancer.Final report of VALG protocol 13 limited

29 September 2023

142

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Total body irradiation in oat cell carcinoma of the bronchus

29 September 2023

144

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies

29 September 2023

145

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes

29 September 2023

146

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Tumor products and potential markers in small cell lung cancer

29 September 2023

147

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response

29 September 2023

148

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Half-body and local chest irradiation as consolidation following response to standard induction chemotherapy for disseminated small cell lung cancer: An Eastern Cooperative Oncology Group Pilot Report

29 September 2023

149

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

VM26 (NSC-122819): A clinical study in advanced cancer of the lung and ovary

29 September 2023

150

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II study of AMSA in lung cancer

29 September 2023

151

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

A critical appraisal of the "human tumor stem-cell assay".

29 September 2023

154

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Exanthem subitum and rotavirus

29 September 2023

156

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Long-term survival five years or more after combination chemotherapy and radiotherapy for small cell lung carcinoma

29 September 2023

158

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Phase II study of vinblastine in small cell carcinoma of the lung

29 September 2023

159

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Hormone production by cultures of small-cell carcinoma of the lung

29 September 2023

160

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus

29 September 2023

161

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung

29 September 2023

163

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy

29 September 2023

164

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

29 September 2023

165

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Chemotherapy of small cell carcinoma of the lung with V. P. 16–213

29 September 2023

166

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Small-cell lung cancer: initial treatment with sequential hemi-body irradiation VS 3-drug systemic chemotherapy

29 September 2023

167

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Leukemia occurring after treatment of small cell lung cancer

29 September 2023

168

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

29 September 2023

172

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology group study

29 September 2023

173

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

Treatment of small cell bronchogenic carcinoma with VM-26

29 September 2023

175

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90032-4

29 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6327578

29 September 2023

1 reference